A Comparison of a PULSE Diet and the TLC Diet on Reproductive, Metabolic Parameters in Women With PCOS

Sponsor
University of Jordan (Other)
Overall Status
Recruiting
CT.gov ID
NCT05428566
Collaborator
Abdul Hameed Shoman Foundation (Other)
110
2
2
22
55
2.5

Study Details

Study Description

Brief Summary

The main objective of the study is to evaluate the effectiveness of a lifestyle program for women with Polycystic Ovary Syndrome (PCOS). The investigators want to assess the efficacy of a pulse-based diet (i.e. a diet that contains lentils, chick-peas, and beans) on the clinical features, biochemical, and hormonal parameters of PCOS compared to the healthy therapeutic lifestyle changes diet.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Pulse-based diet
  • Dietary Supplement: TLC diet
N/A

Detailed Description

The main objective of the study is to identify the effect of pulses on a range of PCOS and metabolic syndrome features. In this parallel clinical trial, 110 (18-35 years old) women with PCOS will be recruited. Participants will be randomly assigned to either a pulse-based diet or a therapeutic lifestyle changes-based diet. The effect of a pulse-based diet on a range of reproductive and metabolic parameters will be evaluated. The results of this study are anticipated to evaluate the therapeutic merits of a pulse-based diet for women with PCOS which would influence dietary guidelines.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
110 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Investigator)
Primary Purpose:
Treatment
Official Title:
A Comparison of a Pulse-Based Diet and the Therapeutic Lifestyle Changes Diet on Reproductive and Metabolic Parameters in Women With Polycystic Ovary Syndrome
Actual Study Start Date :
Jan 1, 2022
Anticipated Primary Completion Date :
Nov 1, 2023
Anticipated Study Completion Date :
Nov 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Pulse-based diet

The pulse diet will include two pulse-based meals; each pulse meal will be consisted of about one cup of non-oil seed pulses, different varieties of pulses (dried beans, peas, lentils, lupine, and chickpeas) will be used. Varieties of pulses will be included and the participants will be provided with recipes and preparation ideas, which would enhance the palatability of pulses, give different taste choices, and ease the follow of the prescribed diet and encourage the participants to consume it for the target duration. The diet is isocaloric and balanced with a fixed macronutrient composition of 28% fat, 55% carbohydrate, and 17% protein.

Dietary Supplement: Pulse-based diet
An isocaloric, balanced diet with a fixed macronutrient composition of 28% fat, 55% carbohydrate, and 17% protein. The pulse diet will include two pulse-based meals; each pulse meal will be consisted of about one cup of non-oil seed pulses, different varieties of pulses (dried beans, peas, lentils, lupine and chickpeas) will be used.

Placebo Comparator: TLC diet

TLC group will be provided with instructions to follow the TLC guidelines and a sample diet plan will be individualized for each participant. The healthy TLC diet will be tailored for each participant according to their energy levels in order to achieve the following amount of nutrients: less than 7% of total calories of saturated fatty acids, up to 10% of total calories of polyunsaturated fat, up to 20% of total calories of monounsaturated fat, less than 200 mg a day of cholesterol, at least 5 to 10 grams a day of soluble fiber. The diet is isocaloric and balanced with a fixed macronutrient composition of 28% fat, 55% carbohydrate, and 17% protein.

Dietary Supplement: TLC diet
An isocaloric, balanced diet with a fixed macronutrient composition of 28% fat, 55% carbohydrate, and 17% protein. The healthy TLC diet will be tailored for each participant according to their energy levels in order to achieve the following amount of nutrients: less than 7% of total calories of saturated fatty acids, up to 10% of total calories of polyunsaturated fat, up to 20% of total calories of monounsaturated fat, less than 200 mg a day of cholesterol, at least 5 to 10 grams a day of soluble fiber.

Outcome Measures

Primary Outcome Measures

  1. Blood concentration of androgen hormone [Change from Baseline sample at 3 months]

    Androgen hormone; testosterone will be evaluated for all participants across the 2 study arms

  2. Ovarian volume [Change from Baseline ovarian morphology at 3 months]

    An experienced ultrasonographer will evaluate the ovarian volume for each ovary.

  3. Ovulatory dysfunction [During nine months]

    Assessed by measuring the duration of the menstrual cycle

  4. Lipid profile [Change from Baseline sample at 3 months]

    Blood Cholesterol will be evaluated for all participants across the 2 study arms

  5. Change in fat mass [Change from Baseline measurements at 3 months]

    Body composition scan using InBody 120 (the body composition analyzer) will be evaluated for all participants across the 2 study arms

  6. Physical activity [Change from Baseline point at 3 months]

    The validated Arabic short form of the International Physical Activity Questionnaire (IPAQ) will be used to evaluate physical activity of all participants. And an overall total physical activity MET-minutes/week score can be computed as: Total physical activity MET-minutes/week = sum of Total (Walking + Moderate + Vigorous) MET- minutes/week scores. ( < 4 : Low), (4-6 Moderate) and ( >6: Vigorous)

  7. Blood pressure [Change from Baseline Systolic Blood Pressure at 3 months]

    In mmHg.(Systolic and Diastolic)

Other Outcome Measures

  1. Previous dietary consumption [Baseline point. (At the beginning of the study)]

    A validated Arabic food frequency questionnaire will be completed by all participants to evaluate previous dietary consumption of these women and compare it with dietary recommendations.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 35 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Female

  • Diagnosis of PCOS in addition to insulin resistance (Homeostasis model assessment (HOMA)-insulin resistance index ≥ 2).

  • Aged 18-35 years

Exclusion Criteria:
  • Individuals that are Keto diet, vegetarian, pregnant, lactating, class 2 obese (body mass index (BMI) ≥35) current smoker, or if they have diabetes, cardiovascular, kidney, liver, or hormonal disease.

  • Individuals taking any medication or supplementation known to affect lipid, glucose, or hormone levels, and/or body weight for at least the last 3 months.

  • Any individual who has an allergy or intolerance to pulses.

Contacts and Locations

Locations

Site City State Country Postal Code
1 The University of Jordan Amman Jordan 11942
2 Jordan University Hospital Amman Jordan

Sponsors and Collaborators

  • University of Jordan
  • Abdul Hameed Shoman Foundation

Investigators

  • Principal Investigator: Shatha Hammad, PhD, The University of Jordan

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
Shatha Hammad, Assistant Professor, Assistant Professor, University of Jordan
ClinicalTrials.gov Identifier:
NCT05428566
Other Study ID Numbers:
  • 2020-2019/27
First Posted:
Jun 23, 2022
Last Update Posted:
Jun 23, 2022
Last Verified:
Jun 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Shatha Hammad, Assistant Professor, Assistant Professor, University of Jordan
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 23, 2022